Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Project:Inflammatory Bowel Disease

Categories:Clinical outcomes Model Economics

5 Publications found

Cost-Effectiveness of Tight Control for Crohn’s Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian Perspective.

b

Journal of the Canadian Association of Gastroenterology

August 1, 2022

p Inflammatory Bowel Disease

c Clinical outcomes Economics Model
A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn’s Disease.

b

The American journal of gastroenterology

August 1, 2021

p Inflammatory Bowel Disease

c Clinical outcomes Economics Highlighted Model
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease.

b

Applied health economics and health policy

July 1, 2021

p Inflammatory Bowel Disease

c Clinical outcomes Economics Model
Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Ulcerative Colitis.

b

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

June 1, 2021

p Inflammatory Bowel Disease

c Clinical outcomes Economics Highlighted Model
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.

b

Gut

April 1, 2020

p Inflammatory Bowel Disease

c Clinical outcomes Economics Model